NAD+
Nicotinamide Adenine Dinucleotide
NAD+ is a coenzyme found in every living cell, essential for energy metabolism, DNA repair, and sirtuin activation. Its decline with age is well-documented — by age 60, NAD+ levels are typically half what they were in youth — making it one of the most actively researched targets in longevity biology.
At a Glance
NAD+ is not just a cellular energy currency. It is also the essential substrate for sirtuins (SIRT1–7), a family of enzymes that regulate gene expression, DNA repair, inflammation, and metabolic homeostasis — the same pathways implicated in aging across multiple organisms.
Its role in PARP activation (DNA repair) adds another dimension: as DNA damage accumulates with age, PARP enzymes consume NAD+ at increasing rates, accelerating the decline. Restoring NAD+ breaks this cycle and supports the cellular repair machinery.
Precursor compounds NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) have been studied as indirect NAD+ restoration strategies, adding another layer to the research landscape around this coenzyme.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
Cellular Energy Metabolism
Acts as an electron carrier in the mitochondrial electron transport chain, essential for ATP production and cellular energy homeostasis.
Sirtuin Activation
Serves as the obligate substrate for SIRT1–7, enabling deacetylation of histones and transcription factors that regulate aging, inflammation, and metabolism.
DNA Repair via PARP
Fuels PARP enzymes responsible for detecting and repairing DNA strand breaks — a process that becomes increasingly NAD+-demanding with age.
Anti-Inflammatory Signaling
SIRT1 activation downregulates NF-κB, reducing chronic low-grade inflammation — a key hallmark of biological aging.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Age-related NAD+ decline studies — documented 40–60% reduction between ages 20 and 60
- Sirtuin pathway research — SIRT1/3 activation and downstream effects on metabolism and longevity
- DNA damage repair capacity in aging cell models
- Neurodegeneration models — NAD+ restoration and cognitive function in rodent aging studies
- Metabolic disease research — NAD+/SIRT1/AMPK axis in obesity and insulin resistance
- Precursor comparison studies — NMN vs NR vs direct NAD+ supplementation models
- Mitochondrial function and biogenesis research
The intersection of energy metabolism, DNA repair, and sirtuin biology makes NAD+ one of the most multidimensional research targets in longevity science.
NAD+, NMN, and NR each offer different administration advantages for research designs targeting the sirtuin and longevity axis.
| Aspect | NAD+ | NMN | NR |
|---|---|---|---|
| Form | Direct coenzyme | Mononucleotide precursor | Riboside precursor |
| Bioavailability | IV: direct; oral: variable | Good oral bioavailability | Good oral bioavailability |
| Research Depth | Foundational — decades | Growing rapidly | Growing rapidly |
| Key Pathway | Direct sirtuin substrate | Converted to NAD+ | Converted to NAD+ |
| Best For | IV research protocols | Oral longevity research | Oral research models |
The following reflects findings from published preclinical and clinical safety assessments where available.
Endogenous molecule — found naturally in every cell; fundamental safety profile
Extensive research base — decades of basic biology plus growing human clinical trial data
Multiple administration routes studied — IV, oral, and precursor strategies all characterized
Oral bioavailability complex — direct NAD+ may not cross cell membranes efficiently; precursors often preferred for oral protocols
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026